Tirzepatide 5mg vs higher doses: what TikTok gets wrong

What did @gabyriquelme.8 actually say?

Honestly, this is a tough one to fact-check. The transcript provided is incoherent, likely a transcription failure from a Spanish-language video. Based on the caption, the creator appears to be responding to another user (@zuleimadelagarza) and sharing that she personally did not respond well to a 5mg dose of what is almost certainly tirzepatide, given the GLP-1 category tag. The caption reads: "Yo a la de 5mg no la quise tanto" which translates roughly to "I didn't like the 5mg one that much." That is the core claim, a personal anecdote about a specific dose not working well for her.

Personal experience content like this is everywhere on GLP-1 TikTok. Creators sharing dose reactions, side effect stories, and injection tips drive enormous engagement. That does not make the information accurate or generalizable, and it does not mean a 5mg dose is inherently problematic. Individual response varies significantly.

Does the science back this up?

Here is the short answer: yes, individual dose response varies, and some people genuinely tolerate or respond better to higher doses. But that does not mean 5mg is universally insufficient or unpleasant.

Tirzepatide's phase 3 SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) tested 5mg, 10mg, and 15mg doses over 72 weeks. All three doses produced statistically significant weight loss compared to placebo. The 5mg group lost a mean of 15% body weight. The 15mg group lost around 20.9%. So yes, higher doses produced more weight loss on average, but the 5mg dose was far from ineffective. Gastrointestinal side effects, including nausea, vomiting, and diarrhea, were also dose-dependent and more common at higher doses.

A person saying they preferred a higher dose is plausible. A person saying 5mg "didn't work" without specifying what that means is harder to evaluate clinically. Titration schedules exist for a reason: the body needs time to adapt to GLP-1 receptor agonists.

What did they get wrong (or right)?

We cannot fully assess accuracy here because the transcript is garbled. What we can say is this: sharing a personal dose preference as a general recommendation is where GLP-1 content creators repeatedly go wrong. If the implication is that 5mg is a bad dose and others should skip it or push higher faster, that is genuinely problematic advice.

Rapid titration outside medical supervision is associated with higher rates of nausea, vomiting, and gastroparesis risk. The FDA-approved titration schedule for tirzepatide starts at 2.5mg for four weeks, moves to 5mg, then increases in 2.5mg increments no more frequently than every four weeks. Skipping or dismissing the 5mg phase because a TikTok creator "didn't like it" is not a clinical reason to do so.

On the other hand, if she is simply sharing her subjective experience without prescribing a dose path to others, that is fair. Personal anecdote, clearly labeled as such, has a legitimate place in patient communities. The problem is that social media rarely keeps those labels clear.

What should you actually know?

GLP-1 receptor agonist dosing is not one-size-fits-all. Full stop. The titration schedules built into tirzepatide and semaglutide protocols exist because gastrointestinal tolerability is the primary reason people discontinue these medications. Research published by Rubino et al. (2022, JAMA) confirmed that discontinuation during early titration is common and often driven by side effects rather than lack of efficacy.

What you feel at 5mg does not predict what you will feel at 10mg or 15mg, and it does not predict how much weight you will lose over a full treatment course. Dose decisions should be made with a licensed prescriber who knows your full health history, not based on TikTok comments about what someone else "liked."

• All three doses of tirzepatide in SURMOUNT-1 produced clinically meaningful weight loss.
• Higher doses mean higher GI side effect risk, not just better results.
• Titration speed should be guided by tolerability, not impatience.
• Compounded versions of these medications are not equivalent to FDA-approved branded drugs in terms of verified potency or purity.

Bottom line

This video appears to be a relatable dose-experience share, which is fine as far as it goes. The concern is downstream: followers who interpret "I didn't like 5mg" as clinical signal to avoid or rush past a dose are making a medical decision based on someone else's anecdote. Your prescriber, not TikTok, should be driving that conversation.